|
Index of reports
> Cases with Neuropathy Peripheral ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include neuropathy peripheral. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of Next >>
Possible Dexamethasone side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Neuropathy Peripheral, Pneumonia, Post Herpetic Neuralgia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-10-01
Velcade
Dosage: 3.4 mg, cyclic
Indication: Multiple Myeloma
Start date: 2011-10-06
End date: 2012-02-02
Other drugs received by patient: Simvastin-Mepha; Enalapril Maleate; Aspirin; Doxazosin Mesylate; Amlodipine; Dyazide
Possible Dexamethasone side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: female, weighing 87.8 kg (193.2 pounds)
Reactions: Neuropathy Peripheral, Upper Respiratory Tract Infection, Urinary Tract Infection, Pleural Effusion, Pyrexia, Leukocytosis, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Mantle Cell Lymphoma
Cytarabine
Dosage: 1.87 g, cyclic
Indication: Mantle Cell Lymphoma
Velcade
Dosage: 0.7 mg/m2, cyclic
Start date: 2012-03-19
Vincristine
Dosage: 2 mg, cyclic
Indication: Mantle Cell Lymphoma
Velcade
Dosage: 2.77 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-12-31
Velcade
Dosage: 0.7 mg/m2, cyclic
Velcade
Dosage: 0.7 mg/m2, cyclic
Start date: 2012-02-26
Rituximab
Dosage: 1 mg/m2, cyclic
Indication: Mantle Cell Lymphoma
Cyclophosphamide
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, unk
Indication: Mantle Cell Lymphoma
Methotrexate
Indication: Mantle Cell Lymphoma
Mesna
Dosage: 600 mg/m2, unk
Indication: Mantle Cell Lymphoma
Other drugs received by patient: Sennosides A+B; Nystatin; Diphenhydramine Hydrochloride; Neupogen; Fluconazole; Zofran; Valtrex; Sodium Chloride; Meperidine HCL; Potassium Chloride; Leucovorin Calcium; Zofran; Sodium Chloride; Sodium Chloride; Sodium Chloride; Heparin; Leucovorin Calcium; Allopurinol; Lovenox; Morphine; Senokot; Cipro / 00042702 /; Lovenox; Prednisolone Acetate; Stomatologicals, Mouth Preparations; Tramadol; Sodium Bicarbonate
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-14
Patient:
Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole
Possible Dexamethasone side effects in 78 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-07
Patient: 78 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Neuropathy Peripheral, Anaemia, Hypotension, Multiple Myeloma, Constipation, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Start date: 2009-01-29
Revlimid
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-01-29
Dexamethasone
Start date: 2009-09-10
End date: 2009-10-01
Revlimid
Administration route: Oral
Start date: 2009-09-10
End date: 2009-10-01
Other drugs received by patient: Heparin; Bisphosphonates
Possible Dexamethasone side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: female
Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Left Ventricular Hypertrophy, Toxic Nodular Goitre, Nasal Congestion, Oesophageal Rupture, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Osteoporosis, Folliculitis, Fall, Gastric Ulcer, Haematemesis, Hyperparathyroidism, Chest Pain, Aortic Arteriosclerosis, Perineurial Cyst, Thyroid Mass, Depression, Decreased Appetite, Renal Failure Acute, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Syncope, Pulmonary Valve Incompetence, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Dysaesthesia, Gait Disturbance, Respiratory Tract Infection, Leukopenia, Vitamin D Deficiency, Weight Decreased, Goitre, Lower Limb Fracture, Herpes Zoster, Hypomagnesaemia, Uterine Leiomyoma, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Chest Discomfort, Stomatitis, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Fatigue, Neuropathy Peripheral, Thrombocytopenia, Sinusitis, RIB Fracture, Polyp, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aredia
Dosage: 90 mg, qmo over 4 hrs
Indication: Multiple Myeloma
Start date: 2001-10-01
End date: 2002-01-01
Aredia
Start date: 2008-07-07
Actos
Dosage: 30 mg, qhs
Indication: Diabetes Mellitus
Dexamethasone
Zometa
Dosage: 4 mg, q2mo infusion over 25 mins every other month
Indication: Multiple Myeloma
End date: 2005-07-21
Other drugs received by patient: Cytoxan; Aspirin; Prednisone; Hepatitis B Vaccine; Velcade; Procrit / 00909301 /; Cyclophosphamide; Alkeran; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Pneumovax 23; Enalapril Maleate; Norvasc; Revlimid; Decadron Phosphate; Chemotherapeutics NOS; Vincristine + Adriamycin + Dexamethasone; Pentamidine; Potassium Chloride; Thalidomide; Polio-Vaccine; Melphalan Hydrochloride; Fortamet; Crestor; Magnesium Oxide; Xanax; Benadryl; Doxil; Avalide; Influenza Vaccine; Augmentin '125'; Metformin Hydrochloride
Possible Dexamethasone side effects in
Reported by a physician from Italy on 2012-08-03
Patient:
Reactions: Pyrexia, Constipation, Disease Progression, Liver Disorder, Herpes Zoster, Cardiac Disorder, Death, Neuropathy Peripheral, Oedema, Thrombocytopenia, Hyperglycaemia, Toxicity To Various Agents, Rash, Gastrointestinal Disorder, Pancreatitis, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Bortezomib
Dosage: 1.3 milligram/sq. meter
Thalidomide
Dosage: 100 milligram
Administration route: Oral
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Thalidomide
Dosage: 200 milligram
Administration route: Oral
Thalidomide
Dosage: 50 milligram
Administration route: Oral
Dexamethasone
Dosage: 40 milligram
Dexamethasone
Dosage: 40 milligram
Bortezomib
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Bortezomib
Dosage: 1 milligram/sq. meter
Thalidomide
Dosage: 100 milligram
Administration route: Oral
Dexamethasone
Dosage: 40 milligram
Bortezomib
Dosage: .7 milligram/sq. meter
Thalidomide
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Other drugs received by patient: Acyclovir; Melphalan Hydrochloride; Neupogen; Neupogen; Cyclophosphamide
Possible Dexamethasone side effects in 64 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient: 64 year old female
Reactions: Neuropathy Peripheral, Insomnia
Drug(s) suspected as cause:
Dexamethasone
Velcade
Possible Dexamethasone side effects in female
Reported by a physician from United States on 2012-08-01
Patient: female, weighing 87.8 kg (193.2 pounds)
Reactions: Neuropathy Peripheral, Upper Respiratory Tract Infection, Urinary Tract Infection, Pleural Effusion, Sinusitis, Leukocytosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Indication: Mantle Cell Lymphoma
Start date: 2012-02-26
Mesna
Dosage: 1122mg in normal saline 2000 ml over 24 hours daily for 3 days on days 2-4
Indication: Mantle Cell Lymphoma
Cytarabine
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: 94 mg over 15 minutes for 1 dose on day 5
Indication: Mantle Cell Lymphoma
Cyclophosphamide
Indication: Mantle Cell Lymphoma
Velcade
Velcade
Dosage: push over 3-5 seconds
Start date: 2012-03-19
End date: 2012-03-19
Methotrexate
Indication: Mantle Cell Lymphoma
Rituximab
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: on days 2-5 and days 12-15
Administration route: Oral
Indication: Mantle Cell Lymphoma
Velcade
Start date: 2011-12-31
Vincristine
Dosage: on day 5 and day 12
Indication: Mantle Cell Lymphoma
Other drugs received by patient: Sodium Chloride; Tramadol HCL; Leucovorin Calcium; Leucovorin Calcium; Unknown Medication; Morphine Sulfate; Sodium Chloride; Neupogen; Zofran; Sennosides-Docusate Sodium; Ondansetron HCL; Potassium Chloride; Sodium Chloride; Heparin; Zofran; Sodium Bicarbonate; Meperidine HCL; Diphenhydramine HCL; Nystatin; Lovenox; Sodium Chloride; Senokot; Allopurinol; Ciprofloxacin HCL; Fluconazole; Lovenox; Prednisolone Acetate; Stomatologicals, Mouth Preparations; Valtrex; Ondansetron HCL
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-31
Patient:
Reactions: Mantle Cell Lymphoma Refractory, Skin Toxicity, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Cardiotoxicity, Thrombocytopenia, Renal Disorder, Drug Effect Decreased, Gastrointestinal Toxicity, Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Mantle Cell Lymphoma, Lung Disorder, Neutropenia, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: on days 1, 4, 8 and 11
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: on day 1 (and day 8 of cycle 1)
Indication: Mantle Cell Lymphoma
Chlorambucil
Dosage: from day 20 to 29.
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: day 1 to 4
Indication: Mantle Cell Lymphoma
Possible Dexamethasone side effects in
Reported by a individual with unspecified qualification from Spain on 2012-07-30
Patient:
Reactions: Colon Cancer, Pulmonary Embolism, Toxicity To Various Agents, Multiple Myeloma, Herpes Zoster, Death, Neuropathy Peripheral, Gastrointestinal Disorder, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3mg/m2 on days 1,4,8 and 11 q 3 weeks
Indication: Multiple Myeloma
Thalomid
Dosage: 200mg daily (escalating doses in the first cycle)
Administration route: Oral
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40mg on days 1-4 and 9-12 at 4-week intervals
Administration route: Oral
Indication: Multiple Myeloma
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-23
Patient: male
Reactions: Cholelithiasis, Neuropathy Peripheral
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 15 milligram
Administration route: Oral
End date: 2012-01-17
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-07-13
Elotuzumab
Dosage: 20 milligram/kilogram
Indication: Multiple Myeloma
Start date: 2011-07-13
End date: 2012-01-11
Dexamethasone
Indication: Multiple Myeloma
Start date: 2011-07-12
End date: 2012-01-18
Other drugs received by patient: Mecobalamin; Pregabalin
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-19
Patient:
Reactions: Mantle Cell Lymphoma Refractory, Skin Toxicity, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Cardiotoxicity, Thrombocytopenia, Drug Effect Decreased, Renal Disorder, Gastrointestinal Toxicity, Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Mantle Cell Lymphoma, Lung Disorder, Neutropenia, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: on day 1 (and day 8 of cycle 1)
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Dosage: as a continuous infusion from day 1 to 4
Indication: Mantle Cell Lymphoma
Velcade
Dosage: on days 1, 4, 8 and 11
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: day 1 to 4
Indication: Mantle Cell Lymphoma
Chlorambucil
Dosage: from day 20 to 29.
Indication: Mantle Cell Lymphoma
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient:
Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Velcade
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Revlimid
Dosage: 15 milligram
Administration route: Oral
Cyclophosphamide
Dosage: 500 milligram/sq. meter
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 milligram/sq. meter
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Possible Dexamethasone side effects in male
Reported by a physician from Japan on 2012-07-18
Patient: male
Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-05-12
End date: 2011-05-25
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-01
Prednisolone
Dosage: 10 milligram
Indication: Multiple Myeloma
Start date: 2012-02-09
End date: 2012-02-17
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-13
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-01-13
End date: 2012-02-03
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-04-13
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-03-30
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-10
End date: 2012-01-07
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2011-09-06
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-09-14
End date: 2011-10-03
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-10-12
End date: 2011-10-22
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-12-11
End date: 2011-12-31
Prednisolone
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2012-02-08
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2012-01-25
End date: 2012-02-11
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa
Possible Dexamethasone side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient: 50 year old male
Reactions: Neuropathy Peripheral
Drug(s) suspected as cause:
Velcade
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Revlimid
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a physician from France on 2012-07-16
Patient:
Reactions: Pulmonary Toxicity, Gastrointestinal Toxicity, Nephropathy Toxic, Anaemia, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Sepsis, Cardiotoxicity, Neutropenia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: continuous infusion for 4 days. form: infusion.
Indication: Mantle Cell Lymphoma
Chlorambucil
Dosage: d20 to d29. one cycle every 35 days.
Indication: Mantle Cell Lymphoma
Bortezomib
Dosage: drug: ps 341 on d1, 4, 8 and 11 of cycle 1.
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: from day 1 to 4.
Indication: Mantle Cell Lymphoma
Mabthera
Dosage: day 1 (and day 8 for cycle 1).
Indication: Mantle Cell Lymphoma
Possible Dexamethasone side effects in female
Reported by a health professional (non-physician/pharmacist) from Greece on 2012-07-11
Patient: female, weighing 96.0 kg (211.2 pounds)
Reactions: Myalgia, Neuropathy Peripheral, Muscular Weakness, Neuralgia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Velcade
Dosage: days 1,4,8,11 of cycle
Start date: 2009-12-14
Velcade
Dosage: days 1,4,8,11 of cycle
Start date: 2010-01-28
Dexamethasone
Dosage: days 1-4, 9-12, 17-20 of cycle
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-10-30
Doxorubicin HCL
Dosage: on day 1
Start date: 2009-12-14
Dexamethasone
Dosage: 1 in 1 month
Administration route: Oral
Start date: 2010-01-29
Doxorubicin HCL
Dosage: on day 1
Start date: 2010-01-28
Velcade
Dosage: days 1,4,8,11 of cycle
Indication: Multiple Myeloma
Start date: 2009-10-30
Dexamethasone
Dosage: days 1-4
Administration route: Oral
Start date: 2009-12-14
Doxorubicin HCL
Dosage: on day 1
Indication: Multiple Myeloma
Start date: 2009-10-30
Possible Dexamethasone side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-10
Patient: 71 year old male, weighing 82.0 kg (180.4 pounds)
Reactions: Prostate Cancer, Anaemia, Cushing's Syndrome, Dysgeusia, Osteoarthritis, Syncope, Neuropathy Peripheral, Fatigue, Arthralgia, Carbuncle, Dehydration, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 1.5 milligram
Administration route: Oral
Indication: Prostate Cancer
Start date: 2008-10-01
Dexamethasone
Dosage: 1.5 milligram
Celecoxib
Dosage: 400 milligram
Indication: Prostate Cancer
Start date: 2008-10-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-04-15
End date: 2011-06-09
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-06-10
End date: 2011-08-03
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2009-12-18
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Prostate Cancer
Start date: 2009-09-14
End date: 2009-12-17
Dexamethasone
Dosage: .75 milligram
Administration route: Oral
Start date: 2009-04-01
Other drugs received by patient: Acetylsalicylacid; Metformin HCL; Metoprolol
Possible Dexamethasone side effects in female
Reported by a lawyer from United States on 2012-07-02
Patient: female
Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Toxic Nodular Goitre, Left Ventricular Hypertrophy, Nasal Congestion, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Folliculitis, Fall, Gastric Ulcer, Hyperparathyroidism, Aortic Arteriosclerosis, Thyroid Mass, Perineurial Cyst, Depression, Renal Failure Acute, Decreased Appetite, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Pulmonary Valve Incompetence, Syncope, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Gait Disturbance, Dysaesthesia, Respiratory Tract Infection, Leukopenia, Weight Decreased, Vitamin D Deficiency, Goitre, Lower Limb Fracture, Herpes Zoster, Uterine Leiomyoma, Hypomagnesaemia, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Stomatitis, Chest Discomfort, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Neuropathy Peripheral, Fatigue, Thrombocytopenia, Sinusitis, RIB Fracture, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aredia
Dosage: 90 mg, qmo over 4 hrs
Indication: Multiple Myeloma
Start date: 2001-10-01
End date: 2002-01-01
Dexamethasone
Aredia
Start date: 2008-07-07
Actos
Dosage: 30 mg, qhs
Indication: Diabetes Mellitus
Zometa
Dosage: 4 mg, q2mo infusion over 25 mins every other month
Indication: Multiple Myeloma
End date: 2005-07-21
Other drugs received by patient: Xanax; Procrit / 00909301 /; Pentamidine Isethionate; Crestor; Enalapril Maleate; Magnesium Oxide; Vincristine + Adriamycin + Dexamethasone; Aspirin; Augmentin '125'; Benadryl; Decadron; Thalidomide; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Avalide; Potassium Chloride; Influenza Vaccine; Melphalan Hydrochloride; Metformin HCL; Doxil; Alkeran; Fortamet; Chemotherapeutics NOS; Hepatitis B Vaccine; Cyclophosphamide; Cytoxan; Pneumovax 23; Polio-Vaccine; Revlimid; Velcade; Prednisone TAB; Norvasc
Possible Dexamethasone side effects in
Reported by a physician from Italy on 2012-06-29
Patient:
Reactions: Anaemia, Febrile Neutropenia, Rash, Multiple Myeloma, Pyrexia, Stem Cell Transplant, Myeloma Recurrence, Neuropathy Peripheral, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: 300 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 20 milligram
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-28
Patient:
Reactions: Neuropathy Peripheral, Adverse Drug Reaction, Neutropenia, Multiple Myeloma, Thrombocytopenia
Drug(s) suspected as cause:
Dexamethasone
Dosage: induction therapy
Prednisone TAB
Dosage: post induction therapy; of a 28-day cycle
Indication: Multiple Myeloma
Cyclophosphamide
Dosage: post induction therapy; days 1, 8, 15, 22
Administration route: Oral
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: induction therapy
Indication: Multiple Myeloma
Bortezomib
Dosage: post-induction therapy, days 1, 8, 15
Indication: Multiple Myeloma
Dexamethasone
Dosage: maintainance therapy
Indication: Multiple Myeloma
Bortezomib
Dosage: induction therapy
Possible Dexamethasone side effects in 78 year old male
Reported by a physician from United States on 2012-06-28
Patient: 78 year old male
Reactions: Neuropathy Peripheral, Injection Site Reaction, Toxic Epidermal Necrolysis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: unk
Administration route: Oral
Start date: 2011-08-01
Velcade
Dosage: unk
Start date: 2011-08-16
End date: 2011-08-16
Velcade
Dosage: unk
Indication: Multiple Myeloma
Start date: 2009-03-01
End date: 2009-05-01
Lenalidomide
Dosage: unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-08-01
Dexamethasone
Dosage: unk
Indication: Multiple Myeloma
Start date: 2009-03-01
End date: 2009-05-01
Possible Dexamethasone side effects in 70 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-27
Patient: 70 year old male
Reactions: Furuncle, Anaemia, Cushing's Syndrome, Dysgeusia, Osteoarthritis, Neuropathy Peripheral, Thrombocytopenia, Leukopenia
Drug(s) suspected as cause:
Celecoxib
Dosage: 400 milligram
Indication: Prostate Cancer Metastatic
Dexamethasone
Indication: Prostate Cancer Metastatic
Start date: 2009-04-01
Dexamethasone
Start date: 2009-07-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2010-06-01
Revlimid
Dosage: 15 milligram
Administration route: Oral
Dexamethasone
Start date: 2010-03-01
Dexamethasone
Possible Dexamethasone side effects in 70 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-26
Patient: 70 year old male
Reactions: Anaemia, Furuncle, Cushing's Syndrome, Osteoarthritis, Dysgeusia, Neuropathy Peripheral, Thrombocytopenia, Leukopenia
Drug(s) suspected as cause:
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2010-06-01
Dexamethasone
Dexamethasone
Start date: 2010-03-01
Celecoxib
Dosage: 400 milligram
Indication: Prostate Cancer Metastatic
Dexamethasone
Start date: 2009-07-01
Revlimid
Dosage: 15 milligram
Administration route: Oral
Dexamethasone
Indication: Prostate Cancer Metastatic
Start date: 2009-04-01
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-06-15
Patient:
Reactions: Anaemia, Multiple Myeloma, Toxicity To Various Agents, Hypokalaemia, Death, Hypophosphataemia, Neuropathy Peripheral, Fatigue, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Carfilzomib
Dosage: days 8, 9, 15, 16 every 28 days
Indication: Multiple Myeloma
Melphalan Hydrochloride
Indication: Multiple Myeloma
Steroids NOS
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: 1.5 to 3 mg/m^2/day
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Cisplatin
Dosage: (3-5 mg/m^2/day) 16 days continuous infusion
Indication: Multiple Myeloma
Carfilzomib
Dosage: day 1, 2
Thalidomide
Indication: Multiple Myeloma
Dexamethasone
Dosage: in the absence of at least partial response (pr), dex increased to 20 mg
Indication: Multiple Myeloma
Bortezomib
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08
Patient:
Reactions: Anaemia, Toxicity To Various Agents, Multiple Myeloma, Hypokalaemia, Death, Hypophosphataemia, Fatigue, Neuropathy Peripheral, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Carfilzomib
Dosage: days 8, 9, 15, 16 every 28 days
Indication: Multiple Myeloma
Melphalan Hydrochloride
Indication: Multiple Myeloma
Cisplatin
Dosage: (3-5 mg/m^2/day) 16 days continuous infusion
Indication: Multiple Myeloma
Dexamethasone
Dosage: in the absence of at least partial response (pr), dex increased to 20 mg
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Bortezomib
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Steroids NOS
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: 1.5 to 3 mg/m^2/day
Indication: Multiple Myeloma
Carfilzomib
Dosage: day 1, 2
Possible Dexamethasone side effects in 78 year old male
Reported by a physician from United States on 2012-06-07
Patient: 78 year old male
Reactions: Neuropathy Peripheral, Injection Site Reaction, Toxic Epidermal Necrolysis
Drug(s) suspected as cause:
Lenalidomide
Dosage: unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-08-01
Velcade
Dosage: unk
Indication: Multiple Myeloma
Start date: 2009-03-01
End date: 2009-05-01
Velcade
Dosage: unk
Start date: 2011-08-01
Dexamethasone
Dosage: unk
Indication: Multiple Myeloma
Start date: 2009-03-01
End date: 2009-05-01
Dexamethasone
Dosage: unk
Administration route: Oral
Start date: 2011-08-01
Possible Dexamethasone side effects in female
Reported by a physician from United States on 2012-06-01
Patient: female, weighing 34.6 kg (76.0 pounds)
Reactions: Weight Decreased, Neuropathy Peripheral
Drug(s) suspected as cause:
Revlimid
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-08-09
Velcade
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-08-09
Dexamethasone
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-08-09
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-05-24
Patient:
Reactions: Off Label Use, Neuropathy Peripheral, Cerebrovascular Accident
Drug(s) suspected as cause:
Cytarabine
Dosage: hd; in h patients; days 43, 44; previous protocol; re-induction phase
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: l:1.5 g/m2, s: 2g/m2, h: 5 g/m2 on days 1, 8, previous protocol, consolidation phase
Mercaptopurine
Dosage: days 1-14, previous protocol, consolidation phase
Prednisone
Dosage: days 1-29, previous protocol, re-induction
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: every 4 weeks, previous protocol, continuation
Elspar
Dosage: 10,000 u/m2 or 25, 000u/m2 on days 2,4,6,8,10,12 previous protocol, remission induction
Indication: Acute Lymphocytic Leukaemia
Cytoxan
Dosage: stable/high, every 8 weeks, previous protocol, continuation
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Vincristine
Dosage: on days 1, 8, 15, 22, previous protocol, remission induction
Methotrexate
Dosage: l:1.5 g/m2, s: 2g/m2, h: 5 g/m2 every 8 weeks during 1 year, previous protocol, continuation phase
Prednisone
Dosage: days 1-29, previous protocol, remission induction
Etoposide
Dosage: on days 22, 29, 32, previous protocol, re-induction
Methotrexate
Dosage: age dependent dose on days 1,8,previous protocol, consolidation
Methotrexate
Dosage: weekly; previous protocol; continuation phase
Cytarabine
Dosage: every 8 weeks, previous protocol, continuation
Cytarabine
Dosage: days 22,29, 32, previous protocol, re-induction
Dexamethasone
Dosage: every 4 weeks, previous protocol, continuation
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Dosage: on days 1, 8 and extra on day 15, previous protocol, re-induction
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: on days 1, 8, 15, 22, previous protocol, re-induction induction
Indication: Acute Lymphocytic Leukaemia
Elspar
Dosage: 10,000 u/m2 or 25,000u/m2 on days 2,4,6,8,10,12 previous protocol, reinduction
Elspar
Dosage: 10,000 u/m2 or 25,000u/m2 thrice weekly(reinduction i, ii), weekly (reinduction i) previous protocol
Elspar
Dosage: 25,000u/m2 weeklyduring first 19 weeks; previous protocol; continuation
Cytarabine
Dosage: on days 22, 29, 32, previous protocol, remission induction
Etoposide
Dosage: on days 22, 29, 32, previous protocol, remission induction
Indication: Acute Lymphocytic Leukaemia
Etoposide
Dosage: every 4 weeks, previous protocol, continuation
Methotrexate
Dosage: age dependent dose on days 1, 22 (extra 8, 15), previous protocol, remission induction
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: previous protocol, continuation phase
Methotrexate
Dosage: age dependent dose on days 1, 22, previous protocol, re-induction phase
Mercaptopurine
Dosage: daily, previous protocol, continuation phase
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Cotrim; Leucovorin Calcium
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-05-16
Patient:
Reactions: Off Label Use, Neuropathy Peripheral, Hyperglycaemia, Neutropenic Sepsis, Pancreatitis, Cerebrovascular Accident, Ketoacidosis, Convulsion
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: on days 1, 8, current protocol, remission induction
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Dosage: on days 1, 8 and extra on day 15, previous protocol, re-induction
Doxorubicin HCL
Dosage: in low, standard and high risk patients; day 1 (reinduction i, ii) and days 1, 8 (in reinduction i)
Cytarabine
Dosage: hd; in s/h patients; days 15-16 in reinduction ii; current protocol
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: age dependent dose on day 8,15,29, current protocol, consolidation
Vincristine
Dosage: on days 1, 8, 15, 22, current protocol, remission induction
Cytarabine
Dosage: every 4 weeks, current protocol, continuation
Mercaptopurine
Dosage: daily, previous protocol, continuation phase
Indication: Acute Lymphocytic Leukaemia
Mercaptopurine
Dosage: days 15-70, current protocol, consolidation phase
Mercaptopurine
Dosage: 50-70 mg/m2, daily, current protocol, continuation phase
Methotrexate
Dosage: age dependent dose on days 1, 22, previous protocol, re-induction phase
Methotrexate
Dosage: weekly; previous protocol; continuation phase
Methotrexate
Dosage: weekly; current protocol; continuation phase
Doxorubicin HCL
Dosage: in s/h patients; every 3 weeks during first 16 weeks, continuation phase,current protocol
Vincristine
Dosage: every 4 weeks, current protocol, continuation phase
Elspar
Dosage: 10,000 u/m2 or 25,000u/m2 on days 2,4,6,8,10,12 previous protocol, reinduction
Elspar
Dosage: 25,000u/m2 weeklyduring first 19 weeks; previous protocol; continuation
Cytarabine
Dosage: on days 22, 29, 32, previous protocol, remission induction
Cytarabine
Dosage: days 22,29, 32, previous protocol, re-induction
Mercaptopurine
Dosage: days 1-14, previous protocol, consolidation phase
Methotrexate
Dosage: age dependent dose on days 1; current protocol, re-induction phase
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: l:1.5 g/m2, s: 2g/m2, h: 5 g/m2 every 8 weeks during 1 year, previous protocol, continuation phase
Prednisone
Dosage: days 1-28, current protocol, remission induction
Prednisone
Dosage: days 1-29, previous protocol, remission induction
Cyclophosphamide
Dosage: stable/high, every 4 weeks, current protocol, continuation
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: l:2.5 g/m2, s/h: 5 g/m2 on days 1, 15,29,43,57, current protocol, consolidation phase
Elspar
Dosage: 10,000 u/m2 or 25, 000u/m2 on days 2,4,6,8,10,12 previous protocol, remission induction
Etoposide
Dosage: on days 22, 29, 32, previous protocol, remission induction
Cyclophosphamide
Dosage: stable/high, every 8 weeks, previous protocol, continuation
Methotrexate
Dosage: age dependent dose on days 1, 22 (extra 8, 15), previous protocol, remission induction
Dexamethasone
Dosage: low risk 8 mg/m2, 5 days, stable/high risk 12 mg/m2, every 4 weeks, current protocol, continuation
Doxorubicin HCL
Dosage: on days 1, 8 and extra on day 15, previous protocol, remission induction
Vincristine
Dosage: on days 1, 8, 15, 22, previous protocol, remission induction
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on days 23-26, 29-32, current protocol, remission-induction
Etoposide
Dosage: every 4 weeks, previous protocol, continuation
Mercaptopurine
Dosage: days 22-35, current protocol, remission-induction
Methotrexate
Dosage: age dependent dose on days 1,8,previous protocol, consolidation
Vincristine
Dosage: on days 1, 8, 15, 22, previous protocol, re-induction induction
Vincristine
Dosage: every 4 weeks, previous protocol, continuation
Cytarabine
Dosage: hd; in h patients; days 43, 44; previous protocol; re-induction phase
Cyclophosphamide
Dosage: on day 26, current protocol, remission-induction
Methotrexate
Dosage: age dependent dose every 4 weeks during 1 year current protocol, continuation phase
Dexamethasone
Dosage: every 4 weeks, previous protocol, continuation
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: l:1.5 g/m2, s: 2g/m2, h: 5 g/m2 on days 1, 8, previous protocol, consolidation phase
Prednisone
Dosage: days 1-29, previous protocol, re-induction induction
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: on days 1, 8, 15, current protocol, re-induction induction
Elspar
Dosage: 10,000 u/m2 or 25,000u/m2 thrice weekly(reinduction i, ii), weekly (reinduction i) previous protocol
Indication: Acute Lymphocytic Leukaemia
Elspar
Dosage: 10,000 u/m2 on days 2,4,6,8,10,12 (15, 17, 19)current protocol, remission induction
Cytarabine
Dosage: every 8 weeks, previous protocol, continuation
Etoposide
Dosage: on days 22, 29, 32, previous protocol, re-induction
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: previous protocol, continuation phase
Methotrexate
Dosage: age dependent dose on days 1, 15 (extra on 8, 22), current protocol, remission-induction
Dexamethasone
Dosage: days 1-8, 15-22, current protocol, remission-induction
Other drugs received by patient: Cotrim; Leucovorin Calcium
Page 1 Next >>
|
